Soteri Skin, the innovative medical skincare line that uses pH correction to provide long-term relief for sensitive and chronic skin condition sufferers, is excited to announce it will be entering India through an exclusive partnership with Clinikally.
Soteri Skin takes “pH-balanced” to the next level and offers long-term pH correction to give eczema sufferers long-lasting results. This move comes at an opportune time; according to Statista , the skin care industry in India is estimated to be worth $27.23 billion
by the end of 2023. Global skincare brands have historically neglected the Indian market due to lower discretionary spending power; however, this trend is sharply changing thanks to an emerging affluent middle class.
With its 63rd ranking in the World Bank's Doing Business 2020 index out of 190 countries worldwide - up from 100th place merely three years ago -India's retail sector has become one of the world's largest and most dynamic destinations for business opportunities today.
“The decision to enter India was largely driven by customer feedback and the market opportunity. Eczema affects 1 in 10 adults globally, and this number is growing rapidly in countries like India. We can't wait to see how customers in India benefit from our products!" said Rafal Pielak, CEO at Soteri Skin .
Soteri Skin was founded by a team that is personally affected by eczema, and formulated by leading dermatologists and Harvard scientist, Rafal Pielak who has worked on brands such as CeraVe, La Roche-Posay, and Skinceuticals…
